Welcome!
Pfizer
US stocks
Estee Lauder, Pfizer, Nike in Morningstar’s list of 10 cheapest wide-moat US stocks
These are companies with “wide economic moats” and “significant advantages” that allow them to successfully fend off competitors for decades.
15 days ago
Company in the news
Pfizer drug helped cancer patients regain weight: study
Pfizer is discussing development plans with regulatory agencies and aims to begin registration-enabling studies in 2025.
September 15, 2024
Digital Economy
AI drug discovery is a US$50 billion opportunity for big pharma
While AI can help, scientists still have to do lots of traditional legwork after the molecule is chosen.
May 10, 2023
Covid-19
BioNTech says its Covid vaccine revenue may be lower this year
It is still not clear how many countries will pursue yet another round of shots later in the year.
January 11, 2022
Tech
Top tech trends to watch in 2022
We tend to overestimate the short-term potential of any new technology and, way underestimate its longer-term potential
December 21, 2021
Global Markets
Omicron — it’s Black Friday!
Fortunes have been made in past fire sales. Happy holidays!
November 29, 2021
Covid-19
Pfizer/BioNTech booster shot restores full Covid protection
"Booster vaccinations could play an important role in sustaining pandemic containment and a return to normalcy."
October 21, 2021
Covid-19
Updated version of Covid-19 vaccine needed by middle of 2022 as new variants mutate, says BioNTech CEO
"This virus will stay, and the virus will further adapt," says Sahin.
October 03, 2021
Environmental, Social and Governance
Pimco helps Chanel stay fashionable with green bonds
Last September, Chanel issued its first sustainability-linked bond priced at EUR600 million with "green strings" attached.
June 18, 2021
Covid-19
Singapore bars travellers from UK amid infection spike, BioNTech claims new vaccines for new variants possible within six weeks
According to Wong, this new strain has not been detected in Singapore yet.
December 22, 2020